GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AtriCure Inc (NAS:ATRC) » Definitions » Cyclically Adjusted PB Ratio

ATRC (AtriCure) Cyclically Adjusted PB Ratio : 3.88 (As of May. 29, 2025)


View and export this data going back to 2005. Start your Free Trial

What is AtriCure Cyclically Adjusted PB Ratio?

As of today (2025-05-29), AtriCure's current share price is $33.54. AtriCure's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was $8.65. AtriCure's Cyclically Adjusted PB Ratio for today is 3.88.

The historical rank and industry rank for AtriCure's Cyclically Adjusted PB Ratio or its related term are showing as below:

ATRC' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 2.53   Med: 7.43   Max: 16.6
Current: 3.88

During the past years, AtriCure's highest Cyclically Adjusted PB Ratio was 16.60. The lowest was 2.53. And the median was 7.43.

ATRC's Cyclically Adjusted PB Ratio is ranked worse than
73.19% of 496 companies
in the Medical Devices & Instruments industry
Industry Median: 1.815 vs ATRC: 3.88

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

AtriCure's adjusted book value per share data for the three months ended in Mar. 2025 was $9.185. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $8.65 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


AtriCure Cyclically Adjusted PB Ratio Historical Data

The historical data trend for AtriCure's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AtriCure Cyclically Adjusted PB Ratio Chart

AtriCure Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.17 12.10 6.34 4.50 3.61

AtriCure Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.73 2.75 3.35 3.61 3.73

Competitive Comparison of AtriCure's Cyclically Adjusted PB Ratio

For the Medical Instruments & Supplies subindustry, AtriCure's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AtriCure's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AtriCure's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where AtriCure's Cyclically Adjusted PB Ratio falls into.


;
;

AtriCure Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

AtriCure's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=33.54/8.65
=3.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AtriCure's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, AtriCure's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=9.185/134.9266*134.9266
=9.185

Current CPI (Mar. 2025) = 134.9266.

AtriCure Quarterly Data

Book Value per Share CPI Adj_Book
201506 4.510 100.684 6.044
201509 4.411 100.392 5.928
201512 5.784 99.792 7.820
201603 5.472 100.470 7.349
201606 5.331 101.688 7.074
201609 5.217 101.861 6.911
201612 5.052 101.863 6.692
201703 4.738 102.862 6.215
201706 4.705 103.349 6.143
201709 4.610 104.136 5.973
201712 4.660 104.011 6.045
201803 4.370 105.290 5.600
201806 4.522 106.317 5.739
201809 4.593 106.507 5.819
201812 6.460 105.998 8.223
201903 6.190 107.251 7.787
201906 6.231 108.070 7.780
201909 6.529 108.329 8.132
201912 6.237 108.420 7.762
202003 5.673 108.902 7.029
202006 9.276 108.767 11.507
202009 9.274 109.815 11.395
202012 9.094 109.897 11.165
202103 8.576 111.754 10.354
202106 8.393 114.631 9.879
202109 10.634 115.734 12.397
202112 10.513 117.630 12.059
202203 10.003 121.301 11.127
202206 9.838 125.017 10.618
202209 9.696 125.227 10.447
202212 9.809 125.222 10.569
202303 9.628 127.348 10.201
202306 9.766 128.729 10.236
202309 9.766 129.860 10.147
202312 9.809 129.419 10.226
202403 9.432 131.776 9.657
202406 9.491 132.554 9.661
202409 9.539 133.029 9.675
202412 9.433 133.157 9.558
202503 9.185 134.927 9.185

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


AtriCure  (NAS:ATRC) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


AtriCure Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of AtriCure's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


AtriCure Business Description

Traded in Other Exchanges
N/A
Address
7555 Innovation Way, Mason, OH, USA, 45040
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Executives
Karen Prange director 1108 S RIO VISTA BLVD, FORT LAUDERDALE FL 33316
Maggie Yuen director ONE PENUMBRA PLACE, ALAMEDA CA 94502
Salvatore Privitera officer: VP; Product Development 7555 INNOVATION WAY, MASON OH 45040
Justin J Noznesky officer: SVP, Mktg & Business Develop 7555 INNOVATION WAY, MASON OH 45040
Karl S. Dahlquist officer: Chief Legal Officer 7555 INNOVATION WAY, MASON OH 45040
Vinayak Doraiswamy officer: Chief Scientific Officer 7555 INNOVATION WAY, MASON OH 45040
Deborah Lee Yount officer: Chief Human Resources Officer 7555 INNOVATION WAY, MASON OH 45040
Tonya Austin officer: Chief Human Resources Officer 7555 INNOVATION WAY, MASON OH 45040
Mark A Collar director 382 BISHOPBRIDGE DR, CINCINNATI OH 45255
Angela L Wirick officer: Chief Financial Officer 7555 INNOVATION WAY, MASON OH 45040
Regina E Groves director 5751 COPLEY DRIVE, SAN DIEGO CA 92111
Douglas J Seith officer: SVP of Sales and Marketing 7555 INNOVATION WAY, MASON OH 45040
Deborah H Telman director 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Scott William Drake director 9965 FEDERAL DRIVE, COLORADO SPRINGS CO 80921
Sven Wehrwein director